Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families. by Lacson, John Charles A et al.
RESEARCH ARTICLE Open Access
Birth cohort-specific trends of sun-related
behaviors among individuals from an
international consortium of melanoma-
prone families
John Charles A. Lacson1†, Shawn A. Zamani1,2†, Luis Alberto Ribeiro Froes Jr3 , Nandita Mitra4, Lu Qian5,
Scarlet H. Doyle1, Esther Azizi6,7, Claudia Balestrini8, D. Timothy Bishop9, William Bruno10, Blanca Carlos-Ortega11,
Francisco Cuellar12,13, Anne E. Cust14,15, David E. Elder16, Anne-Marie Gerdes17, Paola Ghiorzo10,18,
Thais C. Grazziotin19, Nelleke A. Gruis20, Johan Hansson21, Marko Hočevar22, Veronica Höiom21,
Elizabeth A. Holland23, Christian Ingvar24, Gilles Landman25,26, Alejandra Larre-Borges27, Graham J. Mann15,23,28,
Montserrat Molgo29, Luciana Facure Moredo30, Håkan Olsson24, Jacoba J. Out-Luiting20, Barbara Perić22,
Dace Pjanova31, Susana Puig12,32,33, Julio Salas-Alanis11,34, Helen Schmid23, Karin A. W. Wadt17,
Julia A. Newton-Bishop9, Peter A. Kanetsky1* and on behalf of the GenoMEL Study Group
Abstract
Background: Individuals from melanoma-prone families have similar or reduced sun-protective behaviors
compared to the general population. Studies on trends in sun-related behaviors have been temporally and
geographically limited.
Methods: Individuals from an international consortium of melanoma-prone families (GenoMEL) were retrospectively
asked about sunscreen use, sun exposure (time spent outside), sunburns, and sunbed use at several timepoints over
their lifetime. Generalized linear mixed models were used to examine the association between these outcomes and
birth cohort defined by decade spans, after adjusting for covariates.
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Results: A total of 2407 participants from 547 families across 17 centers were analyzed. Sunscreen use increased
across subsequent birth cohorts, and although the likelihood of sunburns increased until the 1950s birth cohort, it
decreased thereafter. Average sun exposure did not change across the birth cohorts, and the likelihood of sunbed
use increased in more recent birth cohorts. We generally did not find any differences in sun-related behavior when
comparing melanoma cases to non-cases. Melanoma cases had increased sunscreen use, decreased sun exposure,
and decreased odds of sunburn and sunbed use after melanoma diagnosis compared to before diagnosis.
Conclusions: Although sunscreen use has increased and the likelihood of sunburns has decreased in more recent
birth cohorts, individuals in melanoma-prone families have not reduced their overall sun exposure and had an
increased likelihood of sunbed use in more recent birth cohorts. These observations demonstrate partial
improvements in melanoma prevention and suggest that additional intervention strategies may be needed to
achieve optimal sun-protective behavior in melanoma-prone families.
Keywords: Trends, Sun-related behaviors, Sunscreen use, Sun exposure, Sunburn, Sunbed, Melanoma, High-risk
families, Skin Cancer
Background
The incidence of cutaneous malignant melanoma has
been increasing over the past 50 years in populations
that are predominantly fair-skinned [1]. Although rates
have stabilized recently in several parts of the world in-
cluding Australasia and North America, they continue to
rise in most European and South American countries
[1–3]. Exposure to ultraviolet radiation, especially inter-
mittent sun exposure resulting in sunburn, is the main
environmental factor associated with increased melan-
oma risk [4].
In the general population, sun-protective behavior has
improved, evidenced by increased sunscreen use and in-
creased sun protection factor (SPF) [5–8]. However, among
individuals with a family history of melanoma, who have
double to quadruple the risk of developing melanoma com-
pared to the general population [9], sun-seeking and tan-
ning behaviors are still prevalent [10]. In addition, sun-
protective behaviors are suboptimal among children and
adolescents who have a family history of melanoma [10–
13] and among adolescents in the general population [14,
15]. These deficits are notable because ultraviolet radiation
exposure during childhood and adolescence is a strong de-
terminant of melanoma risk [16, 17].
Previous studies on sun-protective behaviors in the
general population were limited to a specific geo-
graphic region, examined trends only within a single
or a few decades, or did not examine behaviors
throughout the lifetime of participants [5, 6, 14, 18–
25]. Studies of sun-related behaviors among individ-
uals with a family history of melanoma mainly fo-
cused on recent exposure and rarely describe trends
over time [10, 12, 26–28].
We report results from a large international study of
melanoma-prone families, in which participants were
queried about sun-related behaviors at several points
over their lifetime, including childhood and adolescence.
We characterize trends in sun-related behavior over
most of the twentieth century by birth cohort and com-
pare between melanoma cases and non-cases. Among




The Melanoma Genetics Consortium, GenoMEL, re-
cruited individuals from melanoma-prone families at 27
centers across the globe. Our study sample included par-
ticipants from 17 GenoMEL centers in Europe, North
and South America, Australia, and the Middle East.
Melanoma-prone families were defined by the presence
of three or more melanoma cases among blood relatives,
or two or more cases in first-degree relatives. Personal
history of melanoma was self-reported or verified from
pathology report, cancer registry, clinical notation, or
death certificate. Participants were mailed a question-
naire that solicited information on demographics, per-
sonal history of melanoma, phenotypic variables, and a
personal residence calendar that captured yearly infor-
mation on location of residence, school and/or work,
and the average number of days per week spent at
school and/or work (Additional file 1). A subsequent
questionnaire administered by GenoMEL research staff
recorded details on personal sun exposure and sun-
protective behaviors at multiple time points across the
life course, using the residence and school/work calen-
dar as memory prompts (Additional file 2). This instru-
ment was adapted from one used in several
epidemiological studies of melanoma and has been pre-
viously validated [29, 30].
Demographics and phenotypic covariates
Information on sex and date of birth were obtained. In-
dividuals were grouped into decade birth cohorts
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starting with the 1910s and ending with the 1980s. We
combined the participants born in 1910s (n = 15) with
those born in 1920s (n = 136). Participants born in the
1990s (n = 29) or 2000s (n = 1) were excluded due to
limited lifecourse information. Phenotypic information
was collected on hair color (red, blonde, light brown,
dark brown, black), eye color (blue, brown/black, other),
and skin complexion (very fair, fair, olive, brown, black,
other). Participants reported burn severity after an hour
of mid-day summer sun exposure without protection
(severe sunburn with skin blistering, painful sunburn
with skin peeling, mildly sunburned with some tanning,
or no sunburn with brown tan), and tanning after re-
peated sun exposure without protection (deep brown
tan, moderate tan, mild tan, or no tan/only freckling).
Additionally, participants reported face freckling in
childhood and as an adult (none, very few, few, some,
many, very many), and the number of moles on the body
(none, few, many, very many).
Sunscreen use, sun exposure, sunburn, and sunbed use
Information on sunscreen use, sun exposure, and sun-
burns was obtained at anchor years of 10, 15, 20, 30, 40
years old, and the year before the completion date of the
survey questionnaire. For each anchor year, participants
were asked about the frequency of sunscreen use while
exposed to sunlight on a five-point scale (1 - never or
hardly ever, 2 - less than half the time, 3 - about half the
time, 4 - more than half the time, 5 - always or almost
always). For participants who reported sunscreen use,
use of sunscreen with a SPF of 8 or higher (yes, no) was
assessed. A SPF-weighted sunscreen variable was formu-
lated by assigning individuals who reported using SPF
less than 8 to having never used sunscreen during that
timepoint.
At each anchor year, participants were asked to report
personal outdoor sun exposure and the number of pain-
ful sunburns that lasted for two or more days. We ob-
tained detailed information on number of hours spent
outside between 9 AM and 5 PM during weekdays,
weekends, and holidays, separately for warmer and
colder months. Holidays were defined as days spent
away from school or work.
Daily average sun exposure (time spent outside in
hours) was calculated separately for weekdays, weekends,
and holidays, combining responses from warmer and
colder months within each anchor year. To calculate
overall sun exposure, a time-weighted integration of
hours spent outdoors was calculated based on 5 days for
weekdays and 2 days for weekend days during work and
school weeks, and 7 days for holiday weeks over the 26
weeks for warmer and colder months, respectively.
Hours of warmer and colder months were then averaged
to generate outdoor hours for the entire year. To
calculate lifetime average sun exposure, data from each
anchor year were assigned to a specific period of life: an-
chor year 10 was assigned to ages 5 to 12, anchor year
15 to ages 13 to 17, anchor year 20 to ages 18 to 24, an-
chor year 30 to ages 25 to 34, anchor year 40 to ages 35
to 44, and the last anchor year to ages 45 and above.
Sun exposure measurements were then averaged over
the number of years recorded for each individual. The
following imputation scheme was used for missing
values: if either the first or last anchor year was missing,
the closest non-missing value was carried backward or
forward. If a missing anchor year was between two non-
missing values, the average of the two adjacent non-
missing values was used. Imputation was done separately
for weekdays, weekends, and holidays, within warmer
and colder months.
Participants reported sunlamp or sunbed use on more
than one occasion (ever, never). This question was asked
only once covering the entire life course and not at each
anchor year. Participants who responded an ever-use of
sunlamps or sunbeds were asked about their age at first-
and last-use.
Statistical analyses
Factor analysis of phenotypic variables
Due to the high covariance of phenotypic variables, fac-
tor analysis was performed. Following components ex-
traction using principal axis method with Varimax
(orthogonal) rotation, three meaningful factors emerged
and were retained for rotation. Each of these compo-
nents had an eigenvalue > 1.00 and have a cumulative
percent variance > 70%. Each variable was loaded on a
component if the rotated factor pattern loading was
greater than 0.40 for that factor and less than 0.40 for
the other two factors. Using this scheme, burnability,
tanability, skin complexion loaded on the first factor;
hair color, eye color, extent of body moles loaded on the
second; and childhood and adulthood face freckles
loaded on the third. Factor-based scores were calculated
per participant. Factors were modeled in a confirmatory
factor analysis and robust maximum likelihood estima-
tion yielded a good fit with the model (RMSEA = 0.05;
CFI = 0.97; SRMR = 0.03). We tested for heterogeneity of
trend by pre- vs. post-diagnosis by introducing an inter-
action term between diagnostic period and birth cohort.
All statistical analyses were conducted using SAS v. 9.4
(Statistical Analysis System, RRID:SCR_008567).
Life course and age group analyses
All statistical analyses were conducted using SAS v. 9.4
(Statistical Analysis System, RRID:SCR_008567). Pre-
dicted population marginal means were estimated using
SAS GLIMMIX procedure; separate models were used
for sunscreen use (including SPF-weighted use), hours of
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sun exposure, ever having sunburns, or ever use of sun-
beds as the outcome and birth cohort as the predictor
(categorical) variable. We conducted trend analyses by
coding birth cohort as an ordinal variable in the model.
All models included random effects to account for cluster-
ing within family, and we used empirical (sandwich) vari-
ance estimators. In the models, sunscreen data were
assumed to follow a gamma distribution, and sun expos-
ure data were assumed to follow a normal distribution.
Due to sparse data, we modeled sunburn data as a bino-
mial outcome. Analyses of sunscreen use commenced
with the 1950 birth cohort, which corresponds to the dec-
ade sunscreen became commercially available [31].
All models were adjusted for sex, center (grouped by
latitude: high northern, mid-high northern, mid north-
ern, southern), and the three factor variables for pheno-
type. We conducted analyses for the entire life course
and within three life periods: 10 years old or younger, 11
to 20 years, and after 20 years old. Life course models
and models for after 20 years old also included a covari-
ate capturing number of years unaffected with melan-
oma, which was equal to the age at diagnosis for cases,
or to the age at interview for non-cases.
Analyses stratified by melanoma status, and before and
after diagnosis
We used the same models as above to obtain predicted
population marginal means and perform tests of trends
after stratifying by melanoma status. We tested for the
difference of each outcome variable by melanoma status
across the birth cohorts by adding melanoma status as a
covariate to the full model. Tests of heterogeneity of
trend were conducted by adding an interaction term be-
tween birth cohort and melanoma status.
For melanoma cases, all outcome variables were fur-
ther defined by whether they occurred before or after
diagnosis and were compared using the SAS GLIMMIX
procedure. Random effects were included in the model
to account for clustering of individuals within families.
Because of implicit individual-matching across the pre-
and post-diagnostic periods, other covariates were not
included in these models. We tested for heterogeneity of
trend by pre- vs. post-diagnosis by introducing an inter-
action term between diagnostic period and birth cohort.
Results
A total of 2407 participants from 547 families across 17
centers were recruited (Table 1). The mean age of par-
ticipants was 52.9 years old (SD = 16), and 59% were fe-
male (Table 2). The majority (60%) of participants were
born in the 1940s, 1950s, or 1960s, with approximately
20% in each decade. Almost half (47.8%) of participants
reported at least one primary cutaneous melanoma.
Sunscreen use
We noted a clear secular trend in average reported fre-
quency of sunscreen use with nearly identical increases
over time across all birth cohorts (Fig. 1a). Sunscreen
use increased as each birth cohort aged, and more recent
cohorts had increased sunscreen use at younger ages
Table 1 Number of families, individual, and melanoma affected or unaffected individuals per GenoMEL center
Latitude Center Families Individuals Unaffected Affected
High northern Copenhagen, DK 26 52 0 52
Lund, SE 6 41 25 16
Stockholm, SE 22 125 89 36
Mid-high northern Leeds, UK 93 303 139 164
Leiden, NL 47 431 309 122
Ljubljana, SI 6 16 2 14
Riga, LV 3 8 5 3
Mid northern Barcelona, ES 35 147 91 56
Genoa, IT 25 79 25 54
Philadelphia, US 31 95 31 64
Tel Aviv, IL 31 127 66 61
Southern Mexico City, MX 2 9 5 4
Montevideo, UY 9 55 42 13
Porto Alegre, BR 17 40 16 24
Santiago, CL 4 10 2 8
São Paulo, BR 15 65 36 29
Sydney, AU 175 804 374 430
Total 17 547 2407 1257 1150
Lacson et al. BMC Public Health          (2021) 21:692 Page 4 of 16
Table 2 Characteristics of GenoMEL participants (N = 2407)
Variable Individuals, n (%)
Age at Interview
Mean (SD) 52.9 (16)



























Gray, hazel or green 1062 (44.1)
Brown or black 464 (19.3)
Missing 7 (0.3)
Skin complexion





Severe burn, blister 194 (8.1)
Painful burn, peel 1032 (42.9)
Mild burn, some tan 959 (39.8)
No burn, brown tan 165 (6.9)
Missing 57 (2.4)
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compared to earlier birth cohorts. Results were similar
after adjusting for SPF (data not shown).
Adjusted average lifetime sunscreen use increased by
birth cohort (per birth cohort β = 0.08, P = 0.004), and
this trend strengthened after weighting by SPF (β = 0.11,
P = 0.0003, Table 3). This trend of increasing sunscreen
with subsequent birth cohort was evident within each
life period, within strata defined by melanoma status,
and before and after melanoma diagnosis. We found no
difference or heterogeneity in trends when comparing
cases and non-cases. Cases had higher average sunscreen
use (adjusted mean difference (AMD) = 1.36, P < 0.0001)
after diagnosis than before diagnosis. All results were
similar after weighting by SPF.
Table 2 Characteristics of GenoMEL participants (N = 2407) (Continued)
Variable Individuals, n (%)
Tanability
No tan or get freckled 266 (11.1)
Moderate tan 1045 (43.4)
Mild or occasional tan 761 (31.6)
Deep tan 272 (11.3)
Missing 63 (2.6)
Childhood face freckles












Very few 798 (33.2)
None 916 (38.1)
Missing 39 (1.6)










High northern 218 (9.1)
Mid-high northern 758 (31.5)
Mid northern 448 (18.6)
Southern 983 (40.8)
a Darker skin includes olive, brown, black and other
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Fig. 1 Trends of average annual sunscreen use a, average annual daily sun exposure (in hours) b, and average annual frequency of sunburns c
over time and by birth cohort among GenoMEL participants
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Table 3 Trends in sunscreen use and sun exposure among GenoMEL participants
Birth
decade
n (%) Sunscreen use Daily sun exposure (hours)
Overall SPF-Weighted Overall During weekdays During weekends During holidays
Overalla
1910–1929 147 (6.4) 2.40 2.29 2.22 2.04 2.67 1.43
1930–1939 351 (15.2) 2.59 2.47 2.59 2.35 3.17 2.89
1940–1949 493 (21.4) 2.57 2.39 2.52 2.19 3.32 2.73
1950–1959 501 (21.7) 2.59 2.37 2.36 1.98 3.27 2.79
1960–1969 482 (20.9) 2.69 2.47 2.35 1.97 3.25 2.89
1970–1979 292 (12.6) 2.87 2.55 2.45 2.13 3.19 2.82
1980–1989 141 (6.1) 2.92 2.76 2.44 2.13 3.17 2.99
Total 2407
Betab 0.08 0.11 −0.01 −0.04 0.04 0.05
Ptrend
a 0.004 0.0003 0.64 0.26 0.26 0.38
10 years old or youngerc
1910–1929 147 (6.4) * * 3.40 2.38 4.30 4.80
1930–1939 351 (15.2) * * 3.48 2.42 4.61 4.83
1940–1949 493 (21.4) 1.19 1.13 3.56 2.47 4.64 4.97
1950–1959 501 (21.7) 1.38 1.23 3.44 2.34 4.54 4.79
1960–1969 482 (20.9) 1.89 1.61 3.42 2.39 4.46 4.66
1970–1979 292 (12.6) 2.47 2.18 3.43 2.41 4.36 4.64
1980–1989 141 (6.1) 3.18 2.99 3.19 2.37 3.95 4.24
Total 2407
Betab 0.41 0.34 −0.03 −0.01 −0.07 −0.08
Ptrend
c < 0.0001 < 0.0001 0.04 0.65 0.003 0.0002
11 to 20 years oldc
1910–1929 147 (6.4) * * 2.79 2.22 3.68 3.29
1930–1939 351 (15.2) 1.32 1.21 2.86 2.20 3.93 3.48
1940–1949 493 (21.4) 1.37 1.23 2.88 2.14 3.92 3.83
1950–1959 501 (21.7) 1.64 1.40 2.85 2.06 3.83 3.94
1960–1969 482 (20.9) 2.10 1.80 2.93 2.13 3.87 4.07
1970–1979 292 (12.6) 2.83 2.42 3.01 2.26 3.79 4.05
1980–1989 141 (6.1) 3.16 2.99 2.73 2.09 3.41 3.53
Total 2407
Betab 0.33 0.27 0.01 −0.01 −0.04 0.09
Ptrend
c < 0.0001 < 0.0001 0.37 0.76 0.04 0.0001
After 20 years olda
1910–1929 147 (6.4) 2.53 2.43 2.22 2.05 2.65 1.41
1930–1939 351 (15.2) 2.79 2.66 2.62 2.38 3.17 2.94
1940–1949 493 (21.4) 2.98 2.78 2.53 2.21 3.30 2.78
1950–1959 501 (21.7) 3.10 2.87 2.37 1.98 3.28 2.83
1960–1969 482 (20.9) 3.20 3.02 2.35 1.97 3.23 2.87
1970–1979 292 (12.6) 3.30 3.05 2.49 2.17 3.17 2.74
1980–1989 141 (6.1) 2.93 2.76 2.51 2.15 3.18 2.97
Total 2407
Betab 0.13 0.10 −0.01 −0.03 0.03 0.03
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Table 3 Trends in sunscreen use and sun exposure among GenoMEL participants (Continued)
Birth
decade
n (%) Sunscreen use Daily sun exposure (hours)
Overall SPF-Weighted Overall During weekdays During weekends During holidays
Ptrend
a 0.0002 0.002 0.83 0.31 0.33 0.64
Non-casesc
1910–1929 77 (6.1) 1.71 1.60 2.59 2.50 2.84 1.39
1930–1939 164 (13.0) 2.15 2.03 2.68 2.44 3.25 2.90
1940–1949 207 (16.5) 2.34 2.14 2.71 2.40 3.50 2.98
1950–1959 268 (21.3) 2.38 2.13 2.50 2.14 3.36 2.98
1960–1969 242 (19.3) 2.76 2.47 2.49 2.11 3.38 3.08
1970–1979 189 (15.0) 2.97 2.68 2.34 1.98 3.17 3.03
1980–1989 110 (8.8) 3.26 3.11 2.48 2.15 3.24 3.21
Total 1257
Betab 0.23 0.24 −0.06 − 0.09 0.01 0.08
Ptrend
c < 0.0001 < 0.0001 0.02 0.001 0.73 0.10
Melanoma Casesa
1910–1929 70 (6.1) 2.70 2.57 2.04 1.81 2.59 1.82
1930–1939 187 (16.3) 2.69 2.55 2.63 2.41 3.15 3.10
1940–1949 286 (24.9) 2.64 2.46 2.39 2.08 3.18 2.63
1950–1959 233 (20.3) 2.83 2.65 2.20 1.80 3.16 2.57
1960–1969 240 (20.9) 2.75 2.59 2.13 1.71 3.09 2.59
1970–1979 103 (9.0) 3.13 2.74 2.52 2.23 3.22 2.44
1980–1989 31 (2.7) 2.92 2.71 1.91 1.47 2.94 2.45
Total 1150
Betab 0.07 0.10 −0.04 −0.07 0.04 −0.07
Ptrend
a 0.08 0.02 0.33 0.11 0.25 0.43
Adjusted Mean Differencea 0.008 0.06 −0.11 −0.12 − 0.07 −0.46
PAMD
a 0.91 0.36 0.11 0.15 0.39 0.002
Pheterogeneity of trend
a 0.69 0.69 0.59 0.85 0.31 0.51
Pre-Diagnosisc
1910–1929 70 (6.1) 2.10 1.94 2.31 1.84 3.07 3.58
1930–1939 187 (16.3) 2.10 1.92 2.83 2.42 3.52 3.78
1940–1949 285 (24.9) 2.07 1.85 2.70 2.12 3.63 3.98
1950–1959 232 (20.3) 2.35 2.14 2.64 1.98 3.58 3.88
1960–1969 239 (20.9) 2.50 2.33 2.72 1.98 3.65 3.96
1970–1979 101 (8.8) 3.15 2.71 3.02 2.26 3.73 4.13
1980–1989 31 (2.7) 3.11 2.86 2.78 2.05 3.57 3.75
Total 1145
Betab 0.18 0.16 0.05 −0.03 0.06 0.05
Ptrend
c < 0.0001 < 0.0001 0.02 0.23 0.01 0.07
Post-Diagnosisc
1910–1929 70 (6.1) 2.79 2.73 1.92 1.86 2.11 2.48
1930–1939 186 (16.4) 3.16 3.07 2.62 2.53 2.86 3.43
1940–1949 283 (25.0) 3.71 3.64 2.42 2.20 2.93 2.74
1950–1959 231 (20.4) 4.08 4.02 2.10 1.68 3.05 3.08
1960–1969 234 (20.6) 3.91 3.87 2.08 1.70 2.98 2.78
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Sun exposure
There was no apparent difference in unadjusted average
sun exposure across birth cohorts or over time period,
but sun exposure decreased as each cohort aged (Fig.
1b). We did not observe a trend in the adjusted lifetime
average daily sun exposure with increasing birth cohort
overall, or during weekdays, weekends, or holidays
(Table 3). At 10 years of age or younger, average daily
sun exposure during weekends (β = − 0.07, Ptrend =
0.003), holidays (β = − 0.08, Ptrend = 0.0002), and overall
(β = − 0.03, Ptrend = 0.04) decreased in more recent birth
cohorts. This trend remained for weekends (β = − 0.07,
Ptrend = 0.04), although sun exposure increased during
holidays (β = 0.09, Ptrend = 0.0001) when participants
were between 11 to 20 years old. We did not observe a
trend in average sun exposure by birth cohort when par-
ticipants were older than 20 years. Cases had less sun ex-
posure during holidays (AMD = − 0.46 h, P = 0.002)
compared to non-cases, otherwise there were no differ-
ences or heterogeneity in trend for sun exposure be-
tween cases and non-cases.
After diagnosis, cases had lower average daily sun
exposure overall (AMD = − 0.41 h, P < 0.0001), which
was primarily driven by differences during weekends
(AMD = − 0.63 h, P < 0.0001), holidays (AMD = − 0.88 h,
P < 0.0001), and to a lesser extent, weekdays (AMD = −
0.08 h, P = 0.04), compared to before diagnosis. Although
there was no heterogeneity of trend overall and during
holidays, there was an accelerated decrease across the
birth cohorts in sun exposure during weekdays (P <
0.0001) and weekends (P = 0.0004) after diagnosis
compared to before diagnosis.
Sunburns
Within birth cohorts, average number of sunburns oc-
curred more frequently at younger ages and decreased
with age (Fig. 1c). The frequency of early life sunburns
increased until the 1950s birth cohort and then de-
creased, with the lowest frequency of sunburns at youn-
ger ages observed in the most recent (1980s) cohort.
Similarly, frequency of sunburns increased and peaked
in 1960 and decreased thereafter.
A total of 1598 (66.4%) respondents reported ever be-
ing sunburned (Table 4). We did not observe a trend of
odds of ever being sunburned with increasing birth co-
hort or within the three life periods after adjustment.
Cohort-specific odds ratios tended to increase until the
1950s cohort and decrease thereafter. This inverted U-
shape trend was verified in models containing a quad-
ratic birth cohort term (data not shown). There was no
difference in odds of ever being sunburned between mel-
anoma cases and non-cases (OR = 1.12, 95%CI: 0.88 to
1.42), nor was there heterogeneity of trend. Cases were
less likely to have sunburns after diagnosis with melan-
oma than before (OR = 0.04, 95%CI: 0.04 to 0.05). The
trend in odds of ever being sunburned across subsequent
birth cohorts was (inverted) U-shaped before diagnosis,
in contrast to an increasing linear trend seen after
diagnosis.
Sunbed use
Less than a third (n = 683, 28.6%) of respondents re-
ported ever using sunbeds (Table 4). There was a
trend of increasing odds of sunbed use with increas-
ing birth cohort (per cohort OR = 1.44, 95%CI:1.28 to
1.62), although the odds ratio estimate for the 1980s
cohort was less than the 1970s cohort. A similar
trend was seen after stratifying by melanoma status.
There was no difference in odds of sunbed use or
heterogeneity in trend when comparing cases and
non-cases. Cases were less likely to use sunbeds after
diagnosis than before diagnosis (OR = 0.19, 95%CI:
0.14 to 0.25). The trend in odds ratios of sunbed use
by birth cohort before diagnosis was similar to that
Table 3 Trends in sunscreen use and sun exposure among GenoMEL participants (Continued)
Birth
decade
n (%) Sunscreen use Daily sun exposure (hours)
Overall SPF-Weighted Overall During weekdays During weekends During holidays
1970–1979 101 (8.9) 4.04 3.91 2.63 2.31 3.33 3.54
1980–1989 29 (2.6) 3.47 3.40 2.28 1.77 3.23 3.09
Total 1134
Betab 0.24 0.24 −0.02 −0.10 0.13 0.04
Ptrend
c < 0.0001 < 0.0001 0.43 0.003 < 0.0001 0.62
Adjusted Mean Differenced 1.36 1.5 −0.41 − 0.08 − 0.63 −0.88
PAMD
d < 0.0001 < 0.0001 < 0.0001 0.04 < 0.0001 < 0.0001
Pheterogeneity of trend
d 0.04 0.001 0.10 < 0.0001 0.0004 0.94
* Sunscreen was not widely available until the 1950s; analyses were limited to 1950s and afterwards
a Model adjusted for sex, phenotype factor variables, center geography, years unaffected, and clustered by family
b Betas represent the average change per unit increase in birth decade, after adjusting for covariates
c Model adjusted for sex, phenotype factor variables, center geography, and clustered by family
d Model adjusted for repeated individual data clustered by family
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Table 4 Adjusted odds ratios and 95% confidence intervals for the association between birth decade and history of sunburns and
sunbed use among GenoMEL participants
Birth decade Sunburn Sunbed use
n Never n (%) Ever n (%) OR 95% CI n Never n (%) Ever n (%) OR 95% CI
Overalla
1910–1929 147 63 (42.9) 84 (57.1) 1.00 REF 144 130 (90.3) 14 (9.7) 1.00 REF
1930–1939 351 147 (41.9) 204 (58.1) 1.07 (0.70 1.63) 349 292 (83.7) 57 (16.3)
1940–1949 493 142 (28.8) 351 (71.2) 2.03 (1.28 3.22) 492 366 (74.4) 126 (25.6) 2.29 (1.48 3.53)
1950–1959 501 132 (26.4) 369 (73.7) 2.20 (1.39 3.48) 497 353 (71.0) 144 (29.0) 3.05 (1.94 4.79)
1960–1969 482 137 (28.4) 345 (71.6) 1.92 (1.10 3.35) 476 294 (61.8) 182 (38.2) 6.12 (3.78 9.89)
1970–1979 292 113 (38.7) 179 (61.3) 1.12 (0.60 2.11) 289 173 (59.9) 116 (40.1) 6.36 (3.53 11.44)
1980–1989 141 75 (53.2) 66 (46.8) 0.69 (0.32 1.46) 138 94 (68.1) 44 (31.9) 4.38 (2.12 9.07)
Total 2407 809 (33.6) 1598 (66.4) 2385 1702 (71.4) 683 (28.6)
Per Cohort OR 0.96 (0.86 1.08) 1.44 (1.28 1.62)
Ptrend 0.52 < 0.0001
10 years old or youngerb
1910–1929 140 93 (66.4) 47 (33.6) 1.00 REF *
1930–1939 331 212 (64.0) 119 (36.0) 1.24 (0.78 1.99) *
1940–1949 467 270 (57.8) 197 (42.2) 1.68 (1.07 2.62) *
1950–1959 481 253 (52.6) 228 (47.4) 2.05 (1.32 3.17) *
1960–1969 464 276 (59.5) 188 (40.5) 1.57 (0.97 2.54) *
1970–1979 283 191 (67.5) 92 (32.5) 1.04 (0.62 1.73) *
1980–1989 139 108 (77.7) 31 (22.3) 0.71 (0.39 1.29) *
Total 2305 1403 (58.3) 902 (41.7)
Per Cohort OR 0.96 (0.90 1.02)
Ptrend 0.21
11 to 20 years oldb
1910–1929 147 68 (46.3) 79 (53.7) 1.00 REF *
1930–1939 349 160 (45.9) 189 (54.1) 1.07 (0.71 1.61) *
1940–1949 493 165 (33.5) 328 (66.5) 1.88 (1.24 2.85) *
1950–1959 501 155 (30.9) 346 (69.1) 2.10 (1.42 3.12) *
1960–1969 479 146 (30.5) 333 (69.5) 2.27 (1.47 3.51) *
1970–1979 292 119 (40.8) 173 (59.2) 1.36 (0.87 2.13) *
1980–1989 141 76 (53.9) 65 (46.1) 0.94 (0.56 1.57) *
Total 2402 889 (36.9) 1513 (63.1)
Per Cohort OR 1.04 (0.97 1.11)
Ptrend 0.30
After 20 years olda
1910–1929 147 114 (77.6) 33 (22.4) 1.00 REF
1930–1939 351 242 (69.0) 109 (31.0) 1.71 (1.04 2.83) *
1940–1949 491 278 (56.6) 213 (43.4) 3.13 (1.89 5.20) *
1950–1959 501 283 (56.5) 218 (43.5) 3.29 (1.97 5.49) *
1960–1969 482 297 (61.6) 185 (38.4) 2.82 (1.60 4.96) *
1970–1979 291 197 (67.7) 94 (32.3) 2.31 (1.24 4.29) *
1980–1989 106 82 (77.4) 24 (22.6) 1.47 (0.67 3.22) *
Total 2369 1493 (63.0) 876 (37.0) *
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Table 4 Adjusted odds ratios and 95% confidence intervals for the association between birth decade and history of sunburns and
sunbed use among GenoMEL participants (Continued)
Birth decade Sunburn Sunbed use
n Never n (%) Ever n (%) OR 95% CI n Never n (%) Ever n (%) OR 95% CI
Per Cohort OR 1.05 (0.96 1.14)
Ptrend 0.33
Non-casesb
1910–1929 77 36 (46.8) 41 (53.3) 1.00 REF 74 67 (90.5) 7 (9.5) 1.00 REF
1930–1939 164 71 (43.3) 93 (56.7) 1.08 (0.60 1.95) 163 199 (84.0) 39 (16.0)
1940–1949 207 78 (37.7) 129 (62.3) 1.64 (0.94 2.86) 207 141 (68.1) 66 (31.9) 2.06 (1.19 3.55)
1950–1959 268 74 (27.6) 194 (72.4) 2.60 (1.47 4.60) 266 178 (66.9) 88 (33.1) 2.11 (1.20 3.55)
1960–1969 242 80 (33.1) 162 (66.9) 2.06 (1.17 3.65) 240 145 (60.4) 95 (39.6) 3.20 (1.89 5.41)
1970–1979 189 81 (42.9) 108 (57.1) 1.19 (0.65 2.15) 189 110 (58.2) 79 (41.8) 3.20 (1.81 5.63)
1980–1989 110 60 (54.6) 50 (45.4) 0.86 (0.44 1.68) 108 72 (66.7) 36 (33.3) 2.03 (1.09 3.77)
Total 1257 480 (38.2) 777 (61.8) 1247 845 (67.8) 402 (32.2)
Per Cohort OR 0.99 (0.91 1.08) 1.19 (1.09 1.30)
Ptrend 0.78 0.0002
Melanoma casesa
1910–1929 70 27 (38.6) 43 (61.4) 1.00 REF 70 63 (90.0) 7 (10.0)) 1.00 REF
1930–1939 187 76 (40.6) 111 (59.4) 1.10 (0.58 2.11) 186 160 (86.0) 26 (14.0))
1940–1949 286 64 (22.4) 222 (77.6) 2.90 (1.48 5.66) 285 225 (79.0) 60 (21.0) 2.06 (1.17 3.64)
1950–1959 233 58 (24.9) 175 (75.1) 2.44 (1.27 4.70) 231 175 (75.8) 56 (24.2) 2.73 (1.47 5.04)
1960–1969 240 57 (23.8) 183 (76.2) 2.68 (1.21 5.93) 236 149 (63.1) 87 (36.9) 6.46 (3.47 12.05)
1970–1979 103 32 (31.1) 71 (68.9) 1.89 (0.79 4.50) 100 63 (63.0) 37 (37.0) 5.80 (2.60 12.93)
1980–1989 31 15 (48.4) 16 (51.6) 0.92 (0.29 2.92) 30 22 (73.3) 8 (26.7) 2.83 (0.81 9.94)
Total 1150 329 (28.6) 821 (71.4) 1138 857 (75.3) 281 (24.7)
Per Cohort OR 1.00 (0.99 1.02) 1.46 (1.24 1.71)
Ptrend 0.29 < 0.0001
ORcases vs non-cases 1.12 (0.88 1.42) 0.89 (0.67 1.16)
Pheterogeneity of trend 0.21 0.21
Pre-Diagnosisb
1910–1929 70 27 (38.6) 43 (61.4) 1.00 REF 70 65 (92.9) 5 (7.1) 1.00 REF
1930–1939 187 77 (41.2) 110 (58.8) 183 163 (89.1) 20 (10.9)
1940–1949 285 63 (22.1) 222 (77.9) 2.62 (1.69 4.05) 285 237 (83.2) 48 (16.8) 1.86 (1.05 3.29)
1950–1959 232 57 (24.6) 175 (75.4) 2.16 (1.44 3.25) 226 182 (80.5) 44 (19.5) 2.26 (1.25 4.07)
1960–1969 238 56 (23.5) 182 (76.5) 2.38 (1.50 3.77) 234 156 (66.7) 78 (33.3) 5.45 (3.26 9.10)
1970–1979 101 31 (30.7) 70 (69.3) 1.68 (0.96 2.92) 99 64 (64.7) 35 (35.3) 4.98 (2.63 9.43)
1980–1989 31 15 (48.4) 16 (51.6) 0.77 (0.34 1.78) 30 23 (76.7) 7 (23.3) 2.05 (0.64 6.58)
Total 1144 326 (28.5) 818 (71.5) 1127 890 (79.0) 237 (21.0)
Per Cohort OR 1.09 (0.98 1.21) 1.41 (1.25 1.59)
Ptrend 0.12 < 0.0001
Post-Diagnosisb
1910–1929 68 66 (97.1) 2 (2.9) 1.00 REF 70 68 (97.1) 2 (2.9) 1.00 REF
1930–1939 184 176 (95.7) 8 (4.3) 187 181 (96.8) 6 (3.2)
1940–1949 281 265 (94.3) 16 (5.7) 2.08 (0.83 5.26) 286 270 (94.4) 16 (5.6) 1.57 (0.64 3.88)
1950–1959 226 199 (88.1) 27 (11.9) 4.40 (1.88 10.29) 233 222 (95.3) 11 (4.7) 1.33 (0.46 3.81)
Lacson et al. BMC Public Health          (2021) 21:692 Page 12 of 16
observed overall (per cohort OR = 1.41, 95%CI:1.25 to
1.59), while there was no trend in sunbed use by
birth cohort after diagnosis.
Discussion
To our knowledge, this is the first study to investigate
trends of sun-related behavior by birth cohort among in-
dividuals in melanoma-prone families. We found in-
creased sunscreen use with increasing birth cohort,
regardless of SPF; and although we saw a trend of in-
creasing odds of sunburn until the 1950s birth cohort, it
decreased thereafter. We found no trends of sun expos-
ure across birth cohorts, but we did note a trend of in-
creasing odds of sunbed use with increasing birth
cohort.
In our analysis of birth cohort-specific trends in sun-
related behaviors by life period, we found that most par-
ticipants experienced a sunburn at 11 to 20 years old, a
time frame in which we also saw a trend of increasing
sun exposure with increasing birth cohort during holi-
days. Sunscreen use was also lower during childhood
(10 years old or younger) and adolescence (11 to 20 years
old) compared to adulthood (after 20 years old). Because
childhood and adolescence are critical windows of ex-
posure for melanoma risk [16, 17], future interventions
should be targeted towards these age groups.
When comparing between melanoma cases and non-
cases, we found no differences in sunscreen use, sun-
burns, sunbed use, and sun exposure overall, during
weekdays and weekends. A previous study also found no
differences in lifetime or childhood sun exposure be-
tween cases and non-cases from melanoma-prone fam-
ilies [32]. These similarities may be due to shared
behavior within families. However, we observed that
cases had greater average sun exposure during holidays
than non-cases, which may support the importance of
intermittent sun exposure in melanoma pathogenesis
within melanoma-prone families. Future research may
need to focus on measures of intermittent sun exposure,
such as the frequency and duration of specific recre-
ational and vacation activities [33], as drivers of individ-
ual melanoma risk among melanoma-prone families.
Previous studies reported that a personal melanoma
diagnosis acts as the strongest catalyst in changing one’s
sun-related behavior [10, 34, 35]. In our study, we found
higher sunscreen use, lower sun exposure, lower odds of
sunburn and sunbed use among cases after diagnosis
than before. However, we found a trend of increasing
risk of sunburn with increasing birth cohort after diag-
nosis – a possible target for further investigation and
prevention strategies.
Although we observed increased sunbed use in more
recent birth cohorts compared to older ones, sunbeds
and indoor tanning have become increasingly regulated
by governments, including outright bans and restricted
use by minors [36, 37]. In the last two decades, sunbed
use has trended downwards among adolescents and
adults globally [36, 38, 39].
We did not ask participants about their beliefs and/or
attitudes regarding sun-related behaviors in our sun-
exposure questionnaire instrument. A preference for
tanned skin has been shown to increase sun-seeking be-
havior and sunbed use, even among high-risk individuals
[10]. We did collect information on whether participants
used sunscreen to prolong their sun exposure (data not
shown), and although 40% who used sunscreen report-
edly never used it to prolong their sun exposure, one-
third (33%) of individuals used sunscreen to prolong
their sun exposure at least half of the time or more
throughout their life. Although we did not collect infor-
mation on perceived melanoma risk, a subset of Geno-
MEL participants (n = 312) previously completed an
Table 4 Adjusted odds ratios and 95% confidence intervals for the association between birth decade and history of sunburns and
sunbed use among GenoMEL participants (Continued)
Birth decade Sunburn Sunbed use
n Never n (%) Ever n (%) OR 95% CI n Never n (%) Ever n (%) OR 95% CI
1960–1969 224 189 (84.4) 35 (15.6) 6.13 (2.60 14.43) 240 228 (95.0) 12 (5.0) 1.34 (0.59 3.04)
1970–1979 95 81 (85.3) 14 (14.7) 5.80 (2.20 15.27) 102 97 (95.1) 5 (4.9) 1.24 (0.38 4.00)
1980–1989 27 20 (74.1) 7 (25.9) 10.53 (3.24 34.29) 31 29 (93.6) 2 (6.5) 1.61 (0.30 8.60)
Total 1105 996 (90.1) 109 (9.9) 1149 1095 (95.3) 54 (4.7)
Per Cohort OR 1.53 (1.32 1.76) 1.03 (0.85 1.25)
Ptrend < 0.0001 0.76
ORpost vs pre
c 0.04 (0.04 0.05) 0.19 (0.14 0.25)
Pheterogeneity of trend
c < 0.0001 0.008
* Participants were only asked about ever use of sunbeds once and were not asked to recall sunbed use at anchor ages
a Model adjusted for sex, phenotype factor variables, center geography, years unaffected and clustered by family
b Model adjusted for sex, phenotype factor variables, center geography, and clustered by family
c Model adjusted for repeated individual data clustered by family
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online survey in which 79% perceived a greater risk of
developing melanoma (or another melanoma) compared
to other people of the same sex, age and skin color [40].
Translating this perception into agency remains a
challenge.
Limitations of our study include our inability to exam-
ine the number of sunburns and number of sunbed ses-
sions as continuous outcomes in our analyses. Both
variables were zero-inflated and highly skewed, and our
attempts at more complex modeling resulted in non-
convergence due to small sample sizes.
Conclusions
Although our study and others have shown improve-
ments in sun-protective behavior over time, melanoma
primary prevention activities remain suboptimal with
room for enhancement during childhood and adoles-
cence. More strategies need to be devised to mitigate
melanoma risk by encouraging increased sunscreen use,
decreased sun exposure and sunbed use among individ-
uals from melanoma-prone families, with consideration
for targeted strategies for individuals younger than 20
years of age.
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